
US Veterans Deserve Better Than a Reconsidered Asbestos Ban
Unfortunately, that progress may not stand unchallenged for so long. Just this June 2025, the federal agency—now under the Trump administration—informed a federal appeals court that it intends to reconsider the last restriction implemented against chrysotile. Although this move may be favorable to certain manufacturers, it does not serve the public interest. Revisiting the regulation of a known carcinogen not only undermines decades of scientific consensus but likewise reopens the door to preventable harm in communities that have already paid the price of inaction. Furthermore, for thousands of veterans in New York and nationwide, this rollback is a reminder of a painful history that risks repeating itself and putting more service members in peril.
The Danger of Reconsidering the Asbestos Ban
Throughout much of the 20th century, asbestos—a naturally occurring mineral—has been vital to the US military, primarily due to its affordability, durability, heat resistance, and fireproofing capabilities. Among its various forms, chrysotile, also known as white asbestos, became the most extensively used, finding its way into nearly every branch of the armed forces. The demand for asbestos especially intensified during World War II, as the military rapidly expanded shipbuilding and base construction, embedding the material in vessels, aircraft, barracks, and vehicles.
The problem is that this heavy reliance has borne devastating consequences. When disturbed, friable asbestos disperses microscopic fibers into the air, which can become embedded in the lungs or other internal organs once inhaled or ingested. The accumulation of this mineral in the body can lead to deadly illnesses, including mesothelioma, lung cancer, asbestosis, and other respiratory diseases. And because these conditions notoriously have a long latency period, many veterans were diagnosed only decades after their service. Today, an estimated 3,000 Americans are diagnosed with mesothelioma annually, and former service members make up roughly 30% of those cases. While this issue has impacted all military branches, the Navy veterans' asbestos exposure emerged as among the most common. In fact, they logged the second highest incidence of mesothelioma, after asbestos exposure of shipyard workers.
This crisis spans all 50 states, with 12,000 to 15,000 Americans dying from asbestos-related diseases each year. Among the most severely affected is New York, home to 688,611 former service members, the seventh-largest veteran population in the US. An updated interactive map shows that from 1999 to 2017, the Empire State recorded 15,205 asbestos-related deaths, wherein 11,320 were linked to lung cancer, 2,830 to mesothelioma, and 1,124 to asbestosis. A large portion of these cases can be traced back to former military installations, such as Plattsburgh Air Force Base and Fort Drum, where asbestos was pervasive. This long and well-documented history is precisely why all types of asbestos, even chrysotile, must remain banned.
The EPA Must Stand Firm in Protecting Public Health
Despite decades of evidence and a clear scientific consensus, the EPA's decision to ban chrysotile asbestos in 2024 has recently come under pressure. This shift appears to stem from legal challenges by manufacturers who argue that the regulation exceeds what is necessary. In response, the EPA informed a federal appeals court in June 2025 that it would revisit the rule—a move that raised serious concerns among public health advocates and veterans' groups alike.
The agency's brief reconsideration was short-lived. In July, it reversed course and announced that it would instead defend the rule's legality in court. Still, the sequence of events—first stepping back, then reaffirming—reflects an alarming degree of uncertainty for a substance as dangerous and well-documented as asbestos. When lives are at stake, especially those of veterans and working-class communities long exposed to this carcinogen, wavering on established protections sends the wrong signal.
The apparent dangers of asbestos—ranging from thousands of diagnoses of cancer and other lethal illnesses to persistent environmental contamination in military bases and high veteran death tolls—are exactly why the chrysotile ban must remain intact. Repealing or weakening it would not only dismiss a painful chapter in public health but also reopen it. The EPA must be firm in this decision, as asbestos has no place in any future we claim to protect.
TIME BUSINESS NEWS

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Wall Street Journal
38 minutes ago
- Wall Street Journal
Why Drug Prices for Some Big Medicines Will Remain High for a Longer Time
Thousands of Medicare recipients will have to wait longer to get some price relief on the expensive cancer drugs they depend on for treatment, while others might not get any reprieve at all. Two little-known provisions in the One Big Beautiful Bill Act signed by President Trump in July will delay Medicare price negotiations for some of the biggest-selling drugs in the world, including Merck's Keytruda, which is used to treat cancer and had $17.9 billion in U.S. sales in 2024. Other drugs, such as Johnson & Johnson's Darzalex, will be excluded entirely.


USA Today
2 hours ago
- USA Today
White House backs away from IVF mandate despite Trump's campaign pledge, Washington Post
WASHINGTON − The White House has no current plans to mandate insurance coverage for in vitro fertilization, despite President Donald Trump's campaign promise to expand access to fertility treatments, The Washington Post reported on Saturday. Trump signed an executive order earlier this year directing the government to expand access to IVF and reduce the costs of the popular fertility treatment. More: Some workers are job hopping for fertility benefits. Employers are trying to keep up. White House officials say expanding IVF access remains a priority, but legal constraints prevent mandating coverage without Congressional approval, and no bill is currently planned, the Post reported. Officials did not immediately respond to a request for comment by USA TODAY. Contributing: Francesca Chambers


Bloomberg
3 hours ago
- Bloomberg
Healthy Living Helps the Aging Brain
A new study published in the Journal of the American Medical Association makes a compelling case that a healthy lifestyle does an aging brain good. That might sound obvious. Eat well, exercise, challenge yourself mentally, have an active social life and you'll be better off for it. Yet researchers are just starting to offer concrete data to support the theory that making conscientious lifestyle changes can lower the risk of dementia, which is estimated to affect some 6 million Americans.